Molecular mechanisms of noncoding RNA and epigenetic regulation in obesity with consequent diabetes mellitus development
作者机构:Department of EndocrinologyPeking University Shenzhen HospitalShenzhen 518036Guangdong ProvinceChina Department of EndocrinologyZhujiang Hospital of Southern Medical UniversityGuangzhou 510282Guangdong ProvinceChina
出 版 物:《World Journal of Diabetes》 (世界糖尿病杂志(英文版)(电子版))
年 卷 期:2023年第14卷第11期
页 面:1621-1631页
核心收录:
学科分类:1002[医学-临床医学] 100201[医学-内科学(含:心血管病、血液病、呼吸系病、消化系病、内分泌与代谢病、肾病、风湿病、传染病)] 10[医学]
基 金:Supported by the Shenzhen Science and Technology Innovation Committee Projects,No.JCYJ20170816105416349 Shenzhen High-level Hospital Construction Fund Shenzhen Key Medical Discipline Construction Fund,No.SZXK010
主 题:Diabetes mellitus Obesity Noncoding RNA Epigenetic regulation Insulin resistance
摘 要:Diabetes mellitus(DM)and obesity have become two of the most prevalent and challenging diseases worldwide,with increasing incidence and serious *** studies have shown that noncoding RNA(ncRNA)and epigenetic regulation play crucial roles in the pathogenesis of DM complicated by *** of the involvement of ncRNA and epigenetic regulation in the pathogenesis of diabetes with obesity has opened new avenues of *** these mechanisms with small molecules or RNA-based therapies may provide a more precise and effective approach to diabetes treatment than traditional *** this review,we discuss the molecular mechanisms of ncRNA and epigenetic regulation and their potential therapeutic targets,and the research prospects for DM complicated with obesity.